218 related articles for article (PubMed ID: 11297265)
1. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
[TBL] [Abstract][Full Text] [Related]
3. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells.
Contessa JN; Reardon DB; Todd D; Dent P; Mikkelsen RB; Valerie K; Bowers GD; Schmidt-Ullrich RK
Clin Cancer Res; 1999 Feb; 5(2):405-11. PubMed ID: 10037190
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
5. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
Contessa JN; Abell A; Valerie K; Lin PS; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):851-8. PubMed ID: 16751066
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization.
Lammering G; Hewit TH; Hawkins WT; Contessa JN; Reardon DB; Lin PS; Valerie K; Dent P; Mikkelsen RB; Schmidt-Ullrich RK
J Natl Cancer Inst; 2001 Jun; 93(12):921-9. PubMed ID: 11416113
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance.
Lammering G; Valerie K; Lin PS; Hewit TH; Schmidt-Ullrich RK
Radiother Oncol; 2004 Sep; 72(3):267-73. PubMed ID: 15450724
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells.
Bonner JA; Buchsbaum DJ; Rogers BE; Grizzle WE; Trummell HQ; Curiel DT; Fiveash JB; Ove R; Raisch KP
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):950-8. PubMed ID: 14967455
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
Toulany M; Dittmann K; Baumann M; Rodemann HP
Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
11. Protracted exposure radiosensitization of experimental human malignant glioma.
Williams JA; Williams JR; Yuan X; Dillehay LE
Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.
Reardon DB; Contessa JN; Mikkelsen RB; Valerie K; Amir C; Dent P; Schmidt-Ullrich RK
Oncogene; 1999 Aug; 18(33):4756-66. PubMed ID: 10467423
[TBL] [Abstract][Full Text] [Related]
13. MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.
Johns TG; McKay MJ; Cvrljevic AN; Gan HK; Taylor C; Xu H; Smyth FE; Scott AM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):572-8. PubMed ID: 20638193
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
15. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
16. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro.
Eke I; Sandfort V; Storch K; Baumann M; Röper B; Cordes N
Int J Radiat Biol; 2007; 83(11-12):793-802. PubMed ID: 18058367
[TBL] [Abstract][Full Text] [Related]
19. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
Hagan M; Yacoub A; Dent P
Clin Cancer Res; 2004 Sep; 10(17):5724-31. PubMed ID: 15355899
[TBL] [Abstract][Full Text] [Related]
20. Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir.
Valerie K; Hawkins W; Farnsworth J; Schmidt-Ullrich R; Lin PS; Amir C; Feden J
Cancer Gene Ther; 2001 Jan; 8(1):3-8. PubMed ID: 11219491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
